Clinical Advisory: Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia (BMT CTN 0901)

Clinical Advisory: Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia (BMT CTN 0901)

Myelodysplastic Syndromes Update

MedlinePlus sent this bulletin at 05/22/2014 01:10 PM EDT

New on the MedlinePlus Myelodysplastic Syndromes page:

Clinical Advisory: Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia (BMT CTN 0901)

05/15/2014 05:05 PM EDT

Source: National Heart, Lung, and Blood Institute, National Cancer Institute - 

Scientists Get Closer to the Stem Cells That May Drive Cancers

05/15/2014 12:00 PM EDT

Researchers say a rare and unique tumor cell appears to help a form of blood cancer mutate and spread

Source: HealthDay